Navigation Links
A sweet solution for Alzheimer's disease?

, McLaurin, and colleagues tested them in transgenic mice with human genes that predispose them to an Alzheimer's-like disease.

When the researchers treated these mice with scyllo-inositol, all of the animals' disease symptoms improved. Cognitive function was improved, amyloid plaques disappeared, inflammation declined, and the mice lived longer.

The scientists found that scyllo-inositol conferred these benefits not only if the mice were treated when they were very young and disease-free, but also if they were treated after the onset of disease.

As a model system, these mice "are pretty good, but they're not a perfect replica of the disease," St George-Hyslop said. The mice do not develop tau tangles, he explained, but they are prone to amyloid plaques, brain inflammation, cognitive disturbance, and early death, just like humans with Alzheimer's disease.

The researchers found that the scyllo-inositol worked better than the epi-inositol version. Scyllo-inositol produced more dramatic benefits overall, while epi-inositol worked only transiently and only when given before disease symptoms appeared.

Scyllo-inositol "is an exciting experimental therapy, but until it has actually been tested in humans, it should not be considered the cure for Alzheimer's disease," St George-Hyslop said. "There are many things that are very promising when done in animal models that turn out to either not work in humans or to have unexpected toxicity."

A public Canadian company called Transition Therapeutics has regulatory approval for clinical trials of scyllo-inositol in humans with Alzheimer's disease and started them about a week ago. St George-Hyslop has a small financial interest in the company.

St George-Hyslop and his colleagues are optimistic that scyllo-inositol will be less toxic to humans than some previous drug candidates for Alzheimer's disease. A vaccine designed to destroy amyloid รข, for example, was first tested s
'"/>

Source:Howard Hughes Medical Institute


Page: 1 2 3

Related biology news :

1. Bad aftertaste? New sensory on/off switch may cure bane of artificial sweetener search
2. Bitter or sweet? The same taste bud can tell the difference
3. UW-Madison scientists zero in on drugs sweet spots
4. Sweet water taste paradoxically predicts sweet taste inhibitors
5. Scientists seek to unwrap the sweet mystery of the sugar coat on bacteria
6. Healing honey: The sweet evidence revealed
7. Attacking cancers sweet tooth is effective strategy against tumors
8. Uncovering DNAs sweet secret
9. A sweet step toward new cancer therapies
10. New law for resolution allows unprecedented sharpness in fluorescence microscopy
11. A radical solution for environmental pollution
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: sweet solution for Alzheimer disease

Breaking Biology News(10 mins):First phase of pan-tropical forest mapping debuting at COP15 2First phase of pan-tropical forest mapping debuting at COP15 3Nanomedicine: Ending 'hit and miss' design 2Nanomedicine: Ending 'hit and miss' design 3Physical education teaching staff play key role in making you like sport 2EVEREST Data Demonstrates Acute Reduction of Mitral Regurgitation Without Procedural Mortality in Patients Treated With the MitraClip 28R 29 Therapy 54381 1EVEREST Data Demonstrates Acute Reduction of Mitral Regurgitation Without Procedural Mortality in Patients Treated With the MitraClip 28R 29 Therapy 54381 2EVEREST Data Demonstrates Acute Reduction of Mitral Regurgitation Without Procedural Mortality in Patients Treated With the MitraClip 28R 29 Therapy 54381 3EVEREST Data Demonstrates Acute Reduction of Mitral Regurgitation Without Procedural Mortality in Patients Treated With the MitraClip 28R 29 Therapy 54381 4Pharmos Corporation Reports 2009 Second Quarter Results 54378 1Pharmos Corporation Reports 2009 Second Quarter Results 54378 2Pharmos Corporation Reports 2009 Second Quarter Results 54378 3Pharmos Corporation Reports 2009 Second Quarter Results 54378 4Pharmos Corporation Reports 2009 Second Quarter Results 54378 5Pharmos Corporation Reports 2009 Second Quarter Results 54378 6Pharmos Corporation Reports 2009 Second Quarter Results 54378 7Pharmos Corporation Reports 2009 Second Quarter Results 54378 8Pharmos Corporation Reports 2009 Second Quarter Results 54378 9Oxygen Biotherapeutics Inc Files 10 K for Fiscal Year Ended April 30 2009 13537 1Oxygen Biotherapeutics Inc Files 10 K for Fiscal Year Ended April 30 2009 13537 2Oxygen Biotherapeutics Inc Files 10 K for Fiscal Year Ended April 30 2009 13537 3